Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

QR Code

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer

Therapeutics: Dual therapy shrinks triple negative breast tumors Two experimental drugs currently in clinical trials as single agents might work better together against triple negative breast cancer. Jeffrey Solzak and Milan Radovich, and colleagues from the Indiana University School of Medicine in...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jeffrey P. Solzak, Rutuja V. Atale, Bradley A. Hancock, Anthony L. Sinn, Karen E. Pollok, David R. Jones, Milan Radovich
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2017
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/4e107a1dad504786a827e6d2492a7acf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy
par: Yu-Hsiang Chen, et autres
Publié: (2017)

Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer
par: Mirjana Prvanović, et autres
Publié: (2021)

Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis
par: Zou H, et autres
Publié: (2016)

Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner.
par: Nandini Dey, et autres
Publié: (2013)

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
par: Guru Sonpavde, et autres
Publié: (2021)

Synergistic effects of concurrent blockade of PI3K and MEK pathways in pancreatic cancer preclinical models.
par: Hua Zhong, et autres
Publié: (2013)

Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
par: Mayuko Uehara, et autres
Publié: (2017)

Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis
par: Hu Y, et autres
Publié: (2021)

TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration
par: Wardhani BWK, et autres
Publié: (2021)

Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
par: Ranjna Madan-Lala, et autres
Publié: (2017)

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
par: Cholpon S. Djuzenova, et autres
Publié: (2021)

INPP4B promotes PI3Kα-dependent late endosome formation and Wnt/β-catenin signaling in breast cancer
par: Samuel J. Rodgers, et autres
Publié: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
par: Swanner J, et autres
Publié: (2015)

TRIM21 and PHLDA3 negatively regulate the crosstalk between the PI3K/AKT pathway and PPP metabolism
par: Jie Cheng, et autres
Publié: (2020)

A triple negative breast cancer: what it is not!
par: Katakkar SB
Publié: (2012)

Triple negative breast cancer: an Indian perspective
par: Akhtar M, et autres
Publié: (2015)

Self-Assembled Dual-Targeted Epirubicin-Hybrid Polydopamine Nanoparticles for Combined Chemo-Photothermal Therapy of Triple-Negative Breast Cancer
par: Li X, et autres
Publié: (2020)

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
par: Wen-Hung Kuo, et autres
Publié: (2012)

The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells
par: Ian J. Huggins, et autres
Publié: (2017)

Ampelopsin Inhibits Cell Viability and Metastasis in Renal Cell Carcinoma by Negatively Regulating the PI3K/AKT Signaling Pathway
par: Zhonghe Zhao, et autres
Publié: (2021)

Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
par: Chiara Giacomelli, et autres
Publié: (2021)

BRCA2 mutations and triple-negative breast cancer.
par: Peter Meyer, et autres
Publié: (2012)

Triple-negative breast cancer: treatment challenges and solutions
par: Collignon J, et autres
Publié: (2016)

Opportunities for metastatic triple negative breast cancer therapy
par: Inna P. Ganshina, et autres
Publié: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
par: Inna P. Ganshina, et autres
Publié: (2021)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
par: Paolo Peterlongo, et autres
Publié: (2021)

Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines
par: I-Lun Hsin, et autres
Publié: (2021)

Single-Layered Flexible Dual Transmissive Rasorbers With Dual/Triple Absorption Bands for Conformal Applications
par: Mehran Manzoor Zargar, et autres
Publié: (2021)

Novel Dual PI3K/mTOR Inhibitor, Apitolisib (GDC-0980), Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells
par: Wioleta Justyna Omeljaniuk, et autres
Publié: (2021)

Negative regulation of bone formation by the transmembrane Wnt antagonist Kremen-2.
par: Jochen Schulze, et autres
Publié: (2010)

The Wnt receptor Ryk is a negative regulator of mammalian dendrite morphogenesis
par: Vanessa Lanoue, et autres
Publié: (2017)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
par: Marina K. Ibragimova, et autres
Publié: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
par: Huebschman ML, et autres
Publié: (2015)

The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
par: Gong Lei, et autres
Publié: (2020)

Modulation of telomere protection by the PI3K/AKT pathway
par: Marinela Méndez-Pertuz, et autres
Publié: (2017)

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
par: Fan Yang, et autres
Publié: (2021)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
par: Ye J, et autres
Publié: (2016)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
par: Anna E. M. Bastiaansen, et autres
Publié: (2020)

Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells
par: YoungJun Ju, et autres
Publié: (2021)

Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
par: L. E. Anselmino, et autres
Publié: (2021)